A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
Conditions:   T Cells;   Colorectal Cancer;   Lynch Syndrome Interventions:   Drug: Naproxen;   Drug: Aspirin Sponsors:   M.D. Anderson Cancer Center;   National Institutes of Health (NIH);   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 9, 2022 Category: Research Source Type: clinical trials

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole
Condition:   Drug Interaction Potentiation Interventions:   Drug: Ilaprazole;   Drug: Naproxen;   Drug: Aceclofenac;   Drug: Celecoxib Sponsor:   Il-Yang Pharm. Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2022 Category: Research Source Type: clinical trials